{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:56:36Z","timestamp":1780563396403,"version":"3.54.1"},"reference-count":20,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,12,19]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The common features of anti-N-methyl-d-aspartate (NMDA) receptor encephalitis are neuropsychiatric symptoms that are often challenging, treatment refractory and take years to recover. Electroconvulsive therapy (ECT) is effective in treating these symptoms in the acute phase, including catatonia and psychiatric issues.<\/jats:p>\n               <jats:p>We describe the case of a man in his 30s with anti-NMDA receptor encephalitis characterised by neuropsychiatric features and treatment-refractory impulsivity, who was successfully treated with ECT. This case suggests that ECT use for behavioural symptoms can be associated with a significant response and may contribute to faster recovery from the disease.<\/jats:p>","DOI":"10.1136\/bcr-2023-258460","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T13:00:19Z","timestamp":1706878819000},"page":"e258460","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-3837","authenticated-orcid":false,"given":"Saehyeon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe City, Hyogo, Japan"},{"name":"Department of Family Medicine, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-7813","authenticated-orcid":false,"given":"Kohei","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Neurology, Kobe University Graduate School of Medicine, Kobe City, Hyogo, Japan"},{"name":"Department of Neurology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki City, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuken","family":"Boku","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe City, Hyogo, Japan"},{"name":"Department of Neuropsychiatry, Kumamoto University Faculty of Life Sciences, Chuo-ku, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"2025082803043678000_17.2.e258460.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70253-2"},{"key":"2025082803043678000_17.2.e258460.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30244-3"},{"key":"2025082803043678000_17.2.e258460.3","doi-asserted-by":"crossref","unstructured":"Ding J , Li X , Tian Z . Clinical features of Coexisting anti-NMDAR and MOG antibody-associated encephalitis: A systematic review and meta-analysis. Front Neurol 2021;12. doi:10.3389\/fneur.2021.711376","DOI":"10.3389\/fneur.2021.711376"},{"key":"2025082803043678000_17.2.e258460.4","doi-asserted-by":"publisher","DOI":"10.2174\/157340011797183184"},{"key":"2025082803043678000_17.2.e258460.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu310"},{"key":"2025082803043678000_17.2.e258460.6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1819.2012.02324.x","article-title":"Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis","volume":"66","author":"Matsumoto","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"key":"2025082803043678000_17.2.e258460.7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YCT.0000000000000334","article-title":"Electroconvulsive therapy in anti-N-methyl-D-aspartate receptor encephalitis: A case report and review of the literature","volume":"32","author":"Coffey","year":"2016","journal-title":"J ECT"},{"key":"2025082803043678000_17.2.e258460.8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chc.2018.07.005","article-title":"Anti-N-methyl d-aspartate receptor encephalitis and electroconvulsive therapy: literature review and future directions","volume":"28","author":"Tanguturi","year":"2019","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"2025082803043678000_17.2.e258460.9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","article-title":"Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases","volume":"12","author":"Warren","year":"2019","journal-title":"Brain Stimul"},{"key":"2025082803043678000_17.2.e258460.10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2021.11.022","article-title":"Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: a case report","volume":"239","author":"Yuan","year":"2022","journal-title":"Schizophr Res"},{"key":"2025082803043678000_17.2.e258460.11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233772","article-title":"Complete cognitive recovery in a severe case of anti-N-methyl-d-aspartate receptor encephalitis treated with electroconvulsive therapy","volume":"13","author":"Leding","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2025082803043678000_17.2.e258460.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.02.010"},{"key":"2025082803043678000_17.2.e258460.13","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and Narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry"},{"key":"2025082803043678000_17.2.e258460.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"2025082803043678000_17.2.e258460.15","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu164"},{"key":"2025082803043678000_17.2.e258460.16","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.2.186"},{"key":"2025082803043678000_17.2.e258460.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-8343(02)00241-4"},{"key":"2025082803043678000_17.2.e258460.18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S2215-0366(17)30330-9","article-title":"Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study","volume":"4","author":"Peer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"2025082803043678000_17.2.e258460.19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.euroneuro.2019.06.002","article-title":"Transdiagnostic modulation of brain networks by electroconvulsive therapy in schizophrenia and major depression","volume":"29","author":"Sambataro","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"2025082803043678000_17.2.e258460.20","doi-asserted-by":"publisher","DOI":"10.1177\/070674371105600104"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-258460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:04:47Z","timestamp":1756375487000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-258460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,2]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bcr-2023-258460"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-258460","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}